Literature DB >> 25295782

An epigenetic "LINK(RNA)" to pathological cardiac hypertrophy.

Jianming Liu1, Da-Zhi Wang2.   

Abstract

Reinduction of fetal gene expression is characteristic of the failing adult heart. Han et al. (2014) demonstrate that a novel cluster of long noncoding RNAs, Myheart, protects the heart from pathological hypertrophy, involving a negative-feedback molecular circuit with the epigenetic Brg1 complex to inhibit fetal-gene reactivation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25295782      PMCID： PMC4886471          DOI： 10.1016/j.cmet.2014.09.011

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


  10 in total

Review 1.  Cardiac plasticity.

Authors:  Joseph A Hill; Eric N Olson
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

2.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

Review 3.  Chromatin remodelling during development.

Authors:  Lena Ho; Gerald R Crabtree
Journal:  Nature       Date:  2010-01-28       Impact factor: 49.962

Review 4.  The genetic basis for cardiac remodeling.

Authors:  Ferhaan Ahmad; J G Seidman; Christine E Seidman
Journal:  Annu Rev Genomics Hum Genet       Date:  2005       Impact factor: 8.929

Review 5.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

6.  Chromatin regulation by Brg1 underlies heart muscle development and disease.

Authors:  Calvin T Hang; Jin Yang; Pei Han; Hsiu-Ling Cheng; Ching Shang; Euan Ashley; Bin Zhou; Ching-Pin Chang
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

7.  Braveheart, a long noncoding RNA required for cardiovascular lineage commitment.

Authors:  Carla A Klattenhoff; Johanna C Scheuermann; Lauren E Surface; Robert K Bradley; Paul A Fields; Matthew L Steinhauser; Huiming Ding; Vincent L Butty; Lillian Torrey; Simon Haas; Ryan Abo; Mohammadsharif Tabebordbar; Richard T Lee; Christopher B Burge; Laurie A Boyer
Journal:  Cell       Date:  2013-01-24       Impact factor: 41.582

8.  The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.

Authors:  Phillip Grote; Lars Wittler; David Hendrix; Frederic Koch; Sandra Währisch; Arica Beisaw; Karol Macura; Gaby Bläss; Manolis Kellis; Martin Werber; Bernhard G Herrmann
Journal:  Dev Cell       Date:  2013-01-28       Impact factor: 12.270

9.  MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

Authors:  Thomas E Callis; Kumar Pandya; Hee Young Seok; Ru-Hang Tang; Mariko Tatsuguchi; Zhan-Peng Huang; Jian-Fu Chen; Zhongliang Deng; Bronwyn Gunn; Janelle Shumate; Monte S Willis; Craig H Selzman; Da-Zhi Wang
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

10.  A long noncoding RNA protects the heart from pathological hypertrophy.

Authors:  Wei Li; Chiou-Hong Lin; Pei Han; Jin Yang; Ching Shang; Sylvia T Nuernberg; Kevin Kai Jin; Weihong Xu; Chieh-Yu Lin; Chien-Jung Lin; Yiqin Xiong; Huanchieh Chien; Bin Zhou; Euan Ashley; Daniel Bernstein; Peng-Sheng Chen; Huei-Sheng Vincent Chen; Thomas Quertermous; Ching-Pin Chang
Journal:  Nature       Date:  2014-08-10       Impact factor: 49.962
  10 in total
  9 in total

Review 1.  Skeletal Muscle Metabolic Alternation Develops Sarcopenia.

Authors:  Qiumei Yang; Piu Chan
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

2.  (MYO)SLIDing Our Way Into the Vascular Pool of Long Noncoding RNAs.

Authors:  Francisco J Naya; Da-Zhi Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10       Impact factor: 8.311

3.  Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy.

Authors:  Wei Yang; Yuan Li; Fawei He; Haixiang Wu
Journal:  BMC Cardiovasc Disord       Date:  2015-07-04       Impact factor: 2.298

4.  WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1.

Authors:  Long Lv; Gong Chen; Jianping Zhou; Jun Li; Jianping Gong
Journal:  J Exp Clin Cancer Res       Date:  2015-10-13

5.  Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats.

Authors:  Yonggang Yuan; Wanzhong Peng; Yongxing Liu; Zesheng Xu
Journal:  Int J Immunopathol Pharmacol       Date:  2017-11-22       Impact factor: 3.219

Review 6.  Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture.

Authors:  Timothy A McKinsey; Thomas M Vondriska; Yibin Wang
Journal:  F1000Res       Date:  2018-10-29

7.  Terminally Differentiated CD4+ T Cells Promote Myocardial Inflammaging.

Authors:  Murilo Delgobo; Margarete Heinrichs; Nils Hapke; DiyaaElDin Ashour; Marc Appel; Mugdha Srivastava; Tobias Heckel; Ioakim Spyridopoulos; Ulrich Hofmann; Stefan Frantz; Gustavo Campos Ramos
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

8.  Long non-coding RNAs link extracellular matrix gene expression to ischemic cardiomyopathy.

Authors:  Zhan-Peng Huang; Yan Ding; Jinghai Chen; Gengze Wu; Masaharu Kataoka; Yongwu Hu; Jian-Hua Yang; Jianming Liu; Stavros G Drakos; Craig H Selzman; Jan Kyselovic; Liang-Hu Qu; Cristobal G Dos Remedios; William T Pu; Da-Zhi Wang
Journal:  Cardiovasc Res       Date:  2016-11-01       Impact factor: 10.787

Review 9.  Long Non-Coding RNAs in Atrial Fibrillation: Pluripotent Stem Cell-Derived Cardiomyocytes as a Model System.

Authors:  Emre Bektik; Douglas B Cowan; Da-Zhi Wang
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.